TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Octapharma AB
Closing information (x1000 DKK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 1,393,258 | 1,300,178 | 1,398,006 |
Financial expenses | 7,983 | 4,505 | 2,853 |
Earnings before taxes | 56,386 | 55,665 | 62,422 |
EBITDA | 208,542 | 233,157 | 285,445 |
Total assets | 941,593 | 1,298,585 | 1,283,122 |
Current assets | 297,346 | 548,974 | 421,820 |
Current liabilities | 240,031 | 196,439 | 200,010 |
Equity capital | 681,987 | 692,954 | 660,998 |
- share capital | 16,706 | 18,178 | 18,529 |
Employees (average) | 984 | 882 | 888 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 72.4% | 53.4% | 51.5% |
Turnover per employee | 1,416 | 1,474 | 1,574 |
Profit as a percentage of turnover | 4.0% | 4.3% | 4.5% |
Return on assets (ROA) | 6.8% | 4.6% | 5.1% |
Current ratio | 123.9% | 279.5% | 210.9% |
Return on equity (ROE) | 8.3% | 8.0% | 9.4% |
Change turnover | 198,396 | -71,366 | -59,551 |
Change turnover % | 17% | -5% | -4% |
Chg. No. of employees | 102 | -6 | 54 |
Chg. No. of employees % | 12% | -1% | 6% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.